Stay updated on Satralizumab in Thyroid Eye Disease Clinical Trial

Sign up to get notified when there's something new on the Satralizumab in Thyroid Eye Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Satralizumab in Thyroid Eye Disease Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.6.3, indicating a new version of the page content. The previous revision tag v3.6.2 was removed.
    Difference
    0.0%
    Check dated 2026-07-03T21:47:33.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision: v3.6.2 is shown, replacing the prior v3.6.0. This reflects a minor update to the page build and does not alter the study content or its presentation.
    Difference
    0.0%
    Check dated 2026-06-27T00:13:55.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Added new help/guide sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment notice stating no participants are being sought. The Intervention/Treatment label was standardized and the page revision updated to v3.6.0.
    Difference
    0.3%
    Check dated 2026-06-12T13:38:27.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The page now displays a new revision number, v3.5.5, indicating a software release update; no study content appears to be modified.
    Difference
    0.0%
    Check dated 2026-06-05T10:11:42.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    A new site revision tag Revision: v3.5.4 was added to the page footer, replacing the previous Revision: v3.5.3. This reflects a backend or UI update tag without altering the study content or user interactions.
    Difference
    0.0%
    Check dated 2026-05-15T05:25:47.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The study title on the page has been updated to the official 'Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease (SatraGO-1)'. The changes also reflect updates to the study's record history with new dates and removal of prior dates, indicating the latest version of the trial record.
    Difference
    0.2%
    Check dated 2026-05-08T00:54:57.000Z thumbnail image

Stay in the know with updates to Satralizumab in Thyroid Eye Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Satralizumab in Thyroid Eye Disease Clinical Trial page.